Skip to main content
. 2023 May 3;15(5):e38513. doi: 10.7759/cureus.38513

Figure 1. Declining trend of VAS score among the study participants (n=64; S-PRP group: 34 and M-PRP group: 30).

Figure 1

S-PRP group: Participants receiving a single intra-articular platelet-rich plasma injection; M-PRP group: Participants receiving two intra-articular platelet-rich plasma injections

VAS: visual analogue scale for pain